Explore
Validate
LearnNBP1-85690
antibody from Novus Biologicals
Targeting: PI3
cementoin, ELAFIN, ESI, SKALP, WAP3, WFDC14
Western blot
ImmunohistochemistryAntibody data
- Antibody Data
- Antigen structure
- References [3]
- Comments [0]
- Validations
- Immunohistochemistry [7]
Submit
Validation data
Reference
Comment
Report error
- Product number
- NBP1-85690 - Provider product page
- Provider
- Novus Biologicals
- Proper citation
- Novus Cat#NBP1-85690, RRID:AB_11026257
- Product name
- Rabbit Polyclonal Trappin-2/Elafin/Skalp Antibody
- Antibody type
- Polyclonal
- Description
- Immunogen affinity purified. Specificity of human Trappin-2/Elafin/Skalp antibody verified on a Protein Array containing target protein plus 383 other non-specific proteins.
- Reactivity
- Human
- Host
- Rabbit
- Isotype
- IgG
- Vial size
- 0.1 ml
- Storage
- Store at 4C short term. Aliquot and store at -20C long term. Avoid freeze-thaw cycles.
Submitted references Attenuated kallikrein-related peptidase activity disrupts desquamation and leads to stratum corneum thickening in human skin equivalent models.
Matrix stiffness exerts biphasic control over monocyte-endothelial adhesion via Rho-mediated ICAM-1 clustering.
Profiling post-centrifugation delay of serum and plasma with antibody bead arrays.
McGovern JA, Meinert C, de Veer SJ, Hollier BG, Parker TJ, Upton Z
The British journal of dermatology 2017 Jan;176(1):145-158
The British journal of dermatology 2017 Jan;176(1):145-158
Matrix stiffness exerts biphasic control over monocyte-endothelial adhesion via Rho-mediated ICAM-1 clustering.
Scott HA, Quach B, Yang X, Ardekani S, Cabrera AP, Wilson R, Messaoudi-Powers I, Ghosh K
Integrative biology : quantitative biosciences from nano to macro 2016 Aug 8;8(8):869-78
Integrative biology : quantitative biosciences from nano to macro 2016 Aug 8;8(8):869-78
Profiling post-centrifugation delay of serum and plasma with antibody bead arrays.
Qundos U, Hong MG, Tybring G, Divers M, Odeberg J, Uhlen M, Nilsson P, Schwenk JM
Journal of proteomics 2013 Dec 16;95:46-54
Journal of proteomics 2013 Dec 16;95:46-54
No comments: Submit comment
Supportive validation
- Submitted by
- Novus Biologicals (provider)
- Main image
- Experimental details
- Immunohistochemistry-Paraffin: Trappin-2/Elafin/Skalp Antibody [NBP1-85690] - Staining of human esophagus shows high expression.
- Submitted by
- Novus Biologicals (provider)
- Main image
- Experimental details
- Immunohistochemistry-Paraffin: Trappin-2/Elafin/Skalp Antibody [NBP1-85690] - Staining of human pancreas shows low expression as expected.
- Submitted by
- Novus Biologicals (provider)
- Main image
- Experimental details
- Immunohistochemistry-Paraffin: Trappin-2/Elafin/Skalp Antibody [NBP1-85690] - Staining of human endometrium shows no positivity in glandular cells as expected.
- Submitted by
- Novus Biologicals (provider)
- Main image
- Experimental details
- Immunohistochemistry-Paraffin: Trappin-2/Elafin/Skalp Antibody [NBP1-85690] - Staining of human esophagus shows moderate membranous positivity in squamous epithelial cells.
- Submitted by
- Novus Biologicals (provider)
- Main image
- Experimental details
- Immunohistochemistry-Paraffin: Trappin-2/Elafin/Skalp Antibody [NBP1-85690] - Staining of human kidney shows no positivity in cells in tubules as expected.
- Submitted by
- Novus Biologicals (provider)
- Main image
- Experimental details
- Immunohistochemistry-Paraffin: Trappin-2/Elafin/Skalp Antibody [NBP1-85690] - Staining in human esophagus and liver tissues using NBP1-85690 antibody. Corresponding PI3 RNA-seq data are presented for the same tissues.
- Submitted by
- Novus Biologicals (provider)
- Main image
- Experimental details
- Immunohistochemistry-Paraffin: Trappin-2/Elafin/Skalp Antibody [NBP1-85690] - Staining of human liver shows no positivity in hepatocytes as expected.
